HealthCor Management’s Albany Molecular Research Inc AMRI Stock Holding History

HealthCor Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,275,000	Closed	-$22.4M	–	84
2015 Q1	$22.4M	Sell	1,275,000 -325,000	-20%	-$5.54M	1.07%	36
2014 Q4	$26M	Buy	1,600,000 +200,000	+14%	+$3.67M	1.45%	28
2014 Q3	$30.9M	Buy	1,400,000 +525,000	+60%	+$10.8M	1.59%	26
2014 Q2	$17.6M	Sell	875,000 -25,000	-3%	-$423K	0.88%	32
2014 Q1	$16.7M	Buy	+900,000	New	+$12.4M	1.01%	29

Other funds holding AMRI

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

HealthCor Management's AMRI Position: Q2 2015 in Review

HealthCor Management sold out of Albany Molecular Research Inc (AMRI) in Q2 2015, closing a stake of 1,275,000 shares — an estimated $22.4M sold.

HealthCor Management first reported a position in AMRI in Q1 2014 and held it in 5 quarters. The position peaked at $30.9M in Q3 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q2 2015.

HealthCor Management reported no remaining Albany Molecular Research Inc position as of Q2 2015 after selling out during the quarter.
HealthCor Management sold 1,275,000 Albany Molecular Research Inc shares in Q2 2015, an estimated $22.4M.
HealthCor Management first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 5 quarters.
HealthCor Management's Albany Molecular Research Inc position peaked at $30.9M in Q3 2014.
131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2015.

Based on HealthCor Management's 13F filing for Q2 2015, filed 14 Aug 2015.